Pharmacy | |||||
Bachelor | TR-NQF-HE: Level 6 | QF-EHEA: First Cycle | EQF-LLL: Level 6 |
Course Code: | UNI316 | ||||
Course Name: | Molecular Visualisation and Therapy | ||||
Semester: | Spring | ||||
Course Credits: |
|
||||
Language of instruction: | Turkish | ||||
Course Condition: | |||||
Does the Course Require Work Experience?: | No | ||||
Type of course: | University Elective | ||||
Course Level: |
|
||||
Mode of Delivery: | E-Learning | ||||
Course Coordinator: | Doç. Dr. SÜREYYA BOZKURT | ||||
Course Lecturer(s): | Dr.Öğr.Üyesi Orçun Can, Burçak Yılmaz,Dr.Öğr.Üyesi Süreyya Bozkurt | ||||
Course Assistants: |
Course Objectives: | The aim of this course for each student; especially learning the molecular imaging methods and basic molecular techniques used in the diagnosis and treatment of various cancers. |
Course Content: | At the end of the Molecular Imaging and Treatment course, students will have information about basic molecular techniques such as molecular imaging methods, targeted therapies and spectral methods, protein analysis methods, which are frequently used in cancer diagnosis and treatment. |
The students who have succeeded in this course;
1) Learns DNA cloning technique and usage areas. 2) Learns the necessary methods for obtaining cell components. 3) Learns the Polymerase Chain Reaction (PCR) method and its usage areas. 4) Learns the types of PCR and its uses in both research and genetic diagnosis. 5) Learns blotting techniques and usage areas and microarray technique. 6) Learns sequencing method and usage areas. 7) Learns Fluorescent in situ Hybridization (FISH) techniques, which is a cytogenetic and molecular cytogenetic method, and its use in the clinic. |
Week | Subject | Related Preparation |
1) | Course Introduction | |
2) | Advanced MR Examination Methods and Clinical Approach I | |
3) | Advanced MR Examination Methods and Clinical Approach II | |
4) | Mechanism of action, clinical use and side effects of anti VEGF targeting therapies | |
5) | DNA Repair Mechanisms and Clinical Implications | |
6) | Molecular targets in non-small cell lung cancer | |
7) | Molecular Imaging and Nuclear Medicine | |
8) | Radionuclide Therapies | |
9) | Radiobiology | |
10) | Cytogenetics | |
11) | Gene Editing Technologies | |
12) | RFLP-PCR | |
13) | Transgenic Mouse Models | |
14) | Spectral Techniques |
Course Notes / Textbooks: | Molecular Biology of the Cell |
References: | Ders Slide ları |
Course Learning Outcomes | 1 |
2 |
3 |
4 |
5 |
6 |
7 |
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Program Outcomes | |||||||||||
1) Applies and develops the universal and social dimensional effects of basic, professional and technological knowledge in the field of pharmacy as well as pharmacy practice interdisciplinary by following legal, deontological and ethical rules. | |||||||||||
2) Defines the terminology related to the pharmacy profession; solves problems , accesses scientific information in the field of pharmacy, after monitoring and evaluating the current literature, applies , communicates, shares by using information technologies effectively and efficiently. | |||||||||||
3) Uses theoretical and practical knowledge about the anatomical structure of the human body, the physiological working principles of systems, biochemical, immunological events in the organism and microorganisms. | |||||||||||
4) Uses basic and advanced analytical techniques and methods by running qualitative/quantitative analyzes and interprets the findings by using appropriate statistical methods. | |||||||||||
5) Defines medicinal plants, herbal drugs and active substances; gains the skills for the development of natural products used for medical purposes. | |||||||||||
6) Applies patient-centered and individualized pharmaceutical care service together with other healthcare personnel within the framework of rational drug use by using the principles of clinical pharmacy, pharmacoeconomics, pharmacotherapy and phytotherapy. | |||||||||||
7) Knows the biological properties, structure-activity relationships, and metabolisms of drugs and gains the skill for the synthesize and development of new drug candidates. | |||||||||||
8) He/She is competent at formulations, production, stability, quality assurance, licensing, patent studies, legal regulations of products containing natural origin and / or synthetic active substances, advanced therapy medicinal products, radiopharmaceuticals and cosmetic products. | |||||||||||
9) Interprets the pharmacokinetic and pharmacodynamic properties of drugs, the factors that change their effect, their toxic effects, pharmacolygical activities and their risk assessment method. Reports the drug interactions and adverse drug reactions, monitors and applies the theoretical/practical knowledge for preventing them. | |||||||||||
10) As a health professional in his/her profession he/she acts as a caregiver, decision maker, communicator, manager, lifelong learner, instructor, leader and researcher, he/she complies with the principles of evidence-based pharmacy by making teamwork for the benefit of society, national and universal values. | |||||||||||
11) He/She works in various fields such as community pharmacy, hospitals, pharmaceutical medical devices, herbal products and cosmetics sectors, health institutions and agencies, clinical research organizations , universities and R&D centers. |
No Effect | 1 Lowest | 2 Average | 3 Highest |
Program Outcomes | Level of Contribution | |
1) | Applies and develops the universal and social dimensional effects of basic, professional and technological knowledge in the field of pharmacy as well as pharmacy practice interdisciplinary by following legal, deontological and ethical rules. | |
2) | Defines the terminology related to the pharmacy profession; solves problems , accesses scientific information in the field of pharmacy, after monitoring and evaluating the current literature, applies , communicates, shares by using information technologies effectively and efficiently. | |
3) | Uses theoretical and practical knowledge about the anatomical structure of the human body, the physiological working principles of systems, biochemical, immunological events in the organism and microorganisms. | |
4) | Uses basic and advanced analytical techniques and methods by running qualitative/quantitative analyzes and interprets the findings by using appropriate statistical methods. | |
5) | Defines medicinal plants, herbal drugs and active substances; gains the skills for the development of natural products used for medical purposes. | |
6) | Applies patient-centered and individualized pharmaceutical care service together with other healthcare personnel within the framework of rational drug use by using the principles of clinical pharmacy, pharmacoeconomics, pharmacotherapy and phytotherapy. | |
7) | Knows the biological properties, structure-activity relationships, and metabolisms of drugs and gains the skill for the synthesize and development of new drug candidates. | |
8) | He/She is competent at formulations, production, stability, quality assurance, licensing, patent studies, legal regulations of products containing natural origin and / or synthetic active substances, advanced therapy medicinal products, radiopharmaceuticals and cosmetic products. | |
9) | Interprets the pharmacokinetic and pharmacodynamic properties of drugs, the factors that change their effect, their toxic effects, pharmacolygical activities and their risk assessment method. Reports the drug interactions and adverse drug reactions, monitors and applies the theoretical/practical knowledge for preventing them. | |
10) | As a health professional in his/her profession he/she acts as a caregiver, decision maker, communicator, manager, lifelong learner, instructor, leader and researcher, he/she complies with the principles of evidence-based pharmacy by making teamwork for the benefit of society, national and universal values. | |
11) | He/She works in various fields such as community pharmacy, hospitals, pharmaceutical medical devices, herbal products and cosmetics sectors, health institutions and agencies, clinical research organizations , universities and R&D centers. |
Semester Requirements | Number of Activities | Level of Contribution |
Homework Assignments | 1 | % 40 |
Presentation | 1 | % 60 |
total | % 100 | |
PERCENTAGE OF SEMESTER WORK | % 100 | |
PERCENTAGE OF FINAL WORK | % | |
total | % 100 |
Activities | Number of Activities | Preparation for the Activity | Spent for the Activity Itself | Completing the Activity Requirements | Workload | ||
Course Hours | 2 | 2 | 10 | 24 | |||
Study Hours Out of Class | 5 | 10 | 50 | ||||
Homework Assignments | 2 | 10 | 10 | 40 | |||
Total Workload | 114 |